Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: ENOV )

48.06 +1.39 (+2.98%)
Streaming Delayed Price Updated: 2:05 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ENOV

< Previous 1 2 3 4 Next >
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
From Enovis Corporation
Via GlobeNewswire
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio. 
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
From Enovis Corporation
Via GlobeNewswire
The Analyst Landscape: 6 Takes On Enovis
Via Benzinga
Analyst Ratings for Enovis
Via Benzinga
4 Analysts Have This to Say About Enovis
Via Benzinga
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
The newest innovation in unloader braces is comfortable, easy to use and effective. 
From Enovis Corporation
Via GlobeNewswire
This Analyst Sees Durable Share Gains, Margin Expansion For Orthopedics-Focused Enovis
William Bliar has initiated coverage on Enovis Corp (NYSE: ENOV), a medical technology company focusing on the orthopedics market valued at approximately $25 billion, experiencing steady growth,... 
Via Benzinga
Enovis Completes Acquisition of LimaCorporate S.p.A
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
This Analyst Selects Enovis As Top Pick For 2024: Spotlight On EMPOWR Revision Launch
Needham analyst Mike Matson reiterated the Buy rating on Enovis Corporation (NYSE: ENOV), raising  
Via Benzinga
Enovis Announces Business Segment Leadership Transition Plan
From Enovis Corporation
Via GlobeNewswire
Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook
From Enovis Corporation
Via GlobeNewswire
Enovis™ to Showcase New Surgical Innovations at AAHKS Annual Meeting
Company unveils new ARVIS® augmented reality system, the EMPOWR™ blade stem and more at upcoming conference in Texas 
From Enovis Corporation
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023
Via Benzinga
ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028
From Enovis Corporation
Via GlobeNewswire
Why Enovis Stock Is Trading Lower Today
Enovis Corporation (NYSE: ENOV) shares are trading lower on Thursday after the company announced a proposed private offering of $400 million of convertible senior notes and issued 
Via Benzinga
Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023
From Enovis Corporation
Via GlobeNewswire
Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Third Quarter 2023 Results Conference Call on November 7th
From Enovis Corporation
Via GlobeNewswire
Big Moves In Orthopedics: Enovis Seals €800M Deal To Acquire LimaCorporate
Enovis Corp (NYSE: ENOV) inked a deal to acquire LimaCorporate S.p.A. for an 
Via Benzinga
Enovis to Acquire LimaCorporate S.p.A.
From Enovis Corporation
Via GlobeNewswire
Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and Patient Specific Instrumentation, will be featured as part of the company’s growing evidence based, high tech... 
From Enovis Corporation
Via GlobeNewswire
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
Enovis Announces Second Quarter 2023 Results and Raises Full-Year Outlook
From Enovis Corporation
Via GlobeNewswire
Enovis to Host Second Quarter 2023 Results Conference Call on August 3rd
From Enovis Corporation
Via GlobeNewswire
Enovis™ Recognized as One of America’s Greatest Workplaces 2023 by Newsweek
From Enovis Corporation
Via GlobeNewswire
Enovis™ Completes Acquisition of Novastep®
From Enovis Corporation
Via GlobeNewswire
Enovis Above-Market Growth Potential Surge Would Come from Market Share Gains and Accretive Acquisitions: Analyst
Needham initiated coverage on Enovis Corp (NYSE: ENOV) with a Buy and a price target of $70, noting that the company can sustain above-market growth in its Reconstructive segment via market share gains... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.